New research has big implications for genomic medicine. Scientists have defined with atomic precision a new genome editing tool that is less than half the size of CRISPR-Cas9 - currently the most reliable genome editing system. This new tool would allow scientists to fit genetic editors into smaller viral delivery systems to fix a variety of diseases.
Researchers have successfully developed a biomarker that will enable Parkinson's disease to be rapidly and inexpensively diagnosed from blood serum samples.
